A067370 Stock Overview
A biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
SunBio,Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩6,570.00 |
| 52 Week High | ₩11,520.00 |
| 52 Week Low | ₩5,580.00 |
| Beta | 0 |
| 11 Month Change | 1.08% |
| 3 Month Change | -12.17% |
| 1 Year Change | -27.96% |
| 33 Year Change | -67.15% |
| 5 Year Change | -48.27% |
| Change since IPO | -40.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| A067370 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 1.7% | -1.5% | 0.9% |
| 1Y | -28.0% | 23.1% | -3.4% |
Return vs Industry: A067370 underperformed the KR Biotechs industry which returned 23.1% over the past year.
Return vs Market: A067370 underperformed the KR Market which returned -3.4% over the past year.
Price Volatility
| A067370 volatility | |
|---|---|
| A067370 Average Weekly Movement | 4.1% |
| Biotechs Industry Average Movement | 8.1% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A067370 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A067370's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | n/a | n/a | www.sunbio.com |
SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide. Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage. The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee.
SunBio,Inc. Fundamentals Summary
| A067370 fundamental statistics | |
|---|---|
| Market cap | ₩78.93b |
| Earnings (TTM) | ₩1.39b |
| Revenue (TTM) | ₩2.17b |
0.0x
P/E Ratio0.0x
P/S RatioIs A067370 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A067370 income statement (TTM) | |
|---|---|
| Revenue | ₩2.17b |
| Cost of Revenue | ₩940.23m |
| Gross Profit | ₩1.23b |
| Other Expenses | -₩163.57m |
| Earnings | ₩1.39b |
Last Reported Earnings
Dec 31, 2014
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A067370 perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yieldn/a
Payout RatioDoes A067370 pay a reliable dividends?
See A067370 dividend history and benchmarks| SunBioInc dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 11 2025 |
| Days until Ex dividend | 28 days |
| Days until Dividend pay date | 133 days |
Does A067370 pay a reliable dividends?
See A067370 dividend history and benchmarks